{"id":2250,"date":"2017-02-15T12:33:57","date_gmt":"2017-02-15T12:33:57","guid":{"rendered":"http:\/\/www.caltagmedsystems.co.uk\/information\/?p=2250"},"modified":"2017-02-15T12:53:16","modified_gmt":"2017-02-15T12:53:16","slug":"exocap-streptavidin-kit","status":"publish","type":"post","link":"https:\/\/www.caltagmedsystems.co.uk\/information\/exocap-streptavidin-kit\/","title":{"rendered":"ExoCap\u2122 Streptavidin Kit"},"content":{"rendered":"<p><em>Purer Exosome Isolation For Your Target Molecule<\/em><\/p>\n<ul>\n<li>Flexible use of biotinylated antibodies to target exosomes<\/li>\n<li>Lower non-specific binding by new &#8216;streptavidin magnetic beads&#8217; and buffers<\/li>\n<li>Better yield than competitor magnetic beads<\/li>\n<li>Easy to use<\/li>\n<\/ul>\n<p>Exosomes are extracellular vesicles secreted by most of cells and contain various marker proteins and nucleic acids, such as microRNAs, fragmented mRNA and DNAs.<\/p>\n<p>The ExoCap\u2122 Streptavidin Kit from <a href=\"http:\/\/www.caltagmedsystems.co.uk\/mbl\/\">MBL International<\/a> is designed for customised isolation and analysis of exosomes or microvesicles, called Extracellular Vesicles (EVs), using the researcher\u2019s biotinylated molecules such as antibodies against exosome surface marker proteins. ExoCap\u2122 uses functionalized Magnosphere\u2122, magnetic micro-particles coated with JSR Life Sciences proprietary hydrophilic polymer to decrease non-specific binding.<\/p>\n<p style=\"text-align: center;\"><a class=\"button_large\" href=\"http:\/\/www.caltagmedsystems.co.uk\/pricing_ordering\/product_detail.php?CI_ID=796070\">View product<\/a><\/p>\n<p><a href=\"https:\/\/www.caltagmedsystems.co.uk\/information\/wp-content\/uploads\/ProtocolExoCap_-Streptavidin-Kit.jpg\"><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-full wp-image-2225\" src=\"https:\/\/www.caltagmedsystems.co.uk\/information\/wp-content\/uploads\/ProtocolExoCap_-Streptavidin-Kit.jpg\" alt=\"ExoCap\u2122 Streptavidin Kit protocol from MBL international for custom exosome isolation\" width=\"2550\" height=\"972\" srcset=\"https:\/\/www.caltagmedsystems.co.uk\/information\/wp-content\/uploads\/ProtocolExoCap_-Streptavidin-Kit.jpg 2550w, https:\/\/www.caltagmedsystems.co.uk\/information\/wp-content\/uploads\/ProtocolExoCap_-Streptavidin-Kit-300x114.jpg 300w, https:\/\/www.caltagmedsystems.co.uk\/information\/wp-content\/uploads\/ProtocolExoCap_-Streptavidin-Kit-768x293.jpg 768w, https:\/\/www.caltagmedsystems.co.uk\/information\/wp-content\/uploads\/ProtocolExoCap_-Streptavidin-Kit-1024x390.jpg 1024w\" sizes=\"auto, (max-width: 2550px) 100vw, 2550px\" \/><\/a><\/p>\n<h4>ExoCap\u2122 Streptavidin Kit Performance Data<\/h4>\n<h5>Western Blot<\/h5>\n<figure id=\"attachment_2226\" aria-describedby=\"caption-attachment-2226\" style=\"width: 2550px\" class=\"wp-caption alignnone\"><a href=\"https:\/\/www.caltagmedsystems.co.uk\/information\/wp-content\/uploads\/UltracentrifugationExoCap_-Streptavidin-Kit.jpg\"><img loading=\"lazy\" decoding=\"async\" class=\"size-full wp-image-2226\" src=\"https:\/\/www.caltagmedsystems.co.uk\/information\/wp-content\/uploads\/UltracentrifugationExoCap_-Streptavidin-Kit.jpg\" alt=\"western blot of ExoCap\u2122 Streptavidin Kit\" width=\"2550\" height=\"572\" srcset=\"https:\/\/www.caltagmedsystems.co.uk\/information\/wp-content\/uploads\/UltracentrifugationExoCap_-Streptavidin-Kit.jpg 2550w, https:\/\/www.caltagmedsystems.co.uk\/information\/wp-content\/uploads\/UltracentrifugationExoCap_-Streptavidin-Kit-300x67.jpg 300w, https:\/\/www.caltagmedsystems.co.uk\/information\/wp-content\/uploads\/UltracentrifugationExoCap_-Streptavidin-Kit-768x172.jpg 768w, https:\/\/www.caltagmedsystems.co.uk\/information\/wp-content\/uploads\/UltracentrifugationExoCap_-Streptavidin-Kit-1024x230.jpg 1024w\" sizes=\"auto, (max-width: 2550px) 100vw, 2550px\" \/><\/a><figcaption id=\"caption-attachment-2226\" class=\"wp-caption-text\">Streptavidin Magnetic Beads with biotinylated antibodies are used for western blot analysis. The band intensity of ExoCap (lane 4 and lane 6) is higher than competitor&#8217;s beads.<\/figcaption><\/figure>\n<h5>Flow Cytometry<\/h5>\n<figure id=\"attachment_2227\" aria-describedby=\"caption-attachment-2227\" style=\"width: 482px\" class=\"wp-caption alignnone\"><a href=\"https:\/\/www.caltagmedsystems.co.uk\/information\/wp-content\/uploads\/ExoCap_-Streptavidin-Kit.jpg\"><img loading=\"lazy\" decoding=\"async\" class=\"wp-image-2227 size-large\" src=\"https:\/\/www.caltagmedsystems.co.uk\/information\/wp-content\/uploads\/ExoCap_-Streptavidin-Kit-482x1024.jpg\" alt=\"ExoCap Streptavidin Kit against competitor. Flow cytometric analysis shows peak shift\" width=\"482\" height=\"1024\" srcset=\"https:\/\/www.caltagmedsystems.co.uk\/information\/wp-content\/uploads\/ExoCap_-Streptavidin-Kit-482x1024.jpg 482w, https:\/\/www.caltagmedsystems.co.uk\/information\/wp-content\/uploads\/ExoCap_-Streptavidin-Kit-141x300.jpg 141w, https:\/\/www.caltagmedsystems.co.uk\/information\/wp-content\/uploads\/ExoCap_-Streptavidin-Kit.jpg 680w\" sizes=\"auto, (max-width: 482px) 100vw, 482px\" \/><\/a><figcaption id=\"caption-attachment-2227\" class=\"wp-caption-text\">ExoCap Streptavidin Kit shows the peak shift of flow cytometry. Competitor A&#8217; streptavidin beads did not show its shift.<\/figcaption><\/figure>\n<h5>CLEIA<\/h5>\n<figure id=\"attachment_2229\" aria-describedby=\"caption-attachment-2229\" style=\"width: 700px\" class=\"wp-caption alignnone\"><a href=\"https:\/\/www.caltagmedsystems.co.uk\/information\/wp-content\/uploads\/ExoCap_Streptavidin-Kit_CLEIA.jpg\"><img loading=\"lazy\" decoding=\"async\" class=\"wp-image-2229 size-large\" src=\"https:\/\/www.caltagmedsystems.co.uk\/information\/wp-content\/uploads\/ExoCap_Streptavidin-Kit_CLEIA-1024x974.jpg\" alt=\"ExoCap Streptavidin Kit and MBL antibodies are able to be used for CLEIA application\" width=\"700\" height=\"666\" srcset=\"https:\/\/www.caltagmedsystems.co.uk\/information\/wp-content\/uploads\/ExoCap_Streptavidin-Kit_CLEIA-1024x974.jpg 1024w, https:\/\/www.caltagmedsystems.co.uk\/information\/wp-content\/uploads\/ExoCap_Streptavidin-Kit_CLEIA-300x285.jpg 300w, https:\/\/www.caltagmedsystems.co.uk\/information\/wp-content\/uploads\/ExoCap_Streptavidin-Kit_CLEIA-768x731.jpg 768w, https:\/\/www.caltagmedsystems.co.uk\/information\/wp-content\/uploads\/ExoCap_Streptavidin-Kit_CLEIA.jpg 1280w\" sizes=\"auto, (max-width: 700px) 100vw, 700px\" \/><\/a><figcaption id=\"caption-attachment-2229\" class=\"wp-caption-text\">ExoCap Streptavidin Kit and MBL antibodies are able to be used for CLEIA application.<\/figcaption><\/figure>\n<p style=\"text-align: left;\">Read More about the ExoCap\u2122 range from MBL International below:<\/p>\n<ul>\n<li><a href=\"https:\/\/www.caltagmedsystems.co.uk\/information\/exosome-research\/\">Exosome Research Overview<\/a><\/li>\n<li><a href=\"https:\/\/www.caltagmedsystems.co.uk\/information\/exocap-exosome-isolation-and-enrichment-kits\/\">ExoCap\u2122 Exosome Isolation and Enrichment Kits<\/a><\/li>\n<li><a href=\"https:\/\/www.caltagmedsystems.co.uk\/information\/monoclonal-antibodies-for-common-exosomal-markers\/\">Monoclonal Antibodies for Common Exosomal Markers<\/a><\/li>\n<\/ul>\n<p style=\"text-align: center;\"><a class=\"button_large\" href=\"http:\/\/www.caltagmedsystems.co.uk\/contact.php\">Any questions? Get in touch!<\/a><\/p>\n<p><a href=\"http:\/\/www.caltagmedsystems.co.uk\/mbl\/\">MBL International<\/a> products are exclusively distributed in the UK and Ireland by Caltag Medsystems Ltd.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Purer Exosome Isolation For Your Target Molecule Flexible use of biotinylated antibodies to target exosomes Lower non-specific binding by new &#8216;streptavidin magnetic beads&#8217; and buffers Better yield than competitor magnetic beads Easy to use Exosomes are extracellular vesicles secreted by<\/p>\n","protected":false},"author":13,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[213],"tags":[215,214,67],"class_list":["post-2250","post","type-post","status-publish","format-standard","hentry","category-exosomes","tag-exocap","tag-exosomes","tag-mbl-international"],"_links":{"self":[{"href":"https:\/\/www.caltagmedsystems.co.uk\/information\/wp-json\/wp\/v2\/posts\/2250","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.caltagmedsystems.co.uk\/information\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.caltagmedsystems.co.uk\/information\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.caltagmedsystems.co.uk\/information\/wp-json\/wp\/v2\/users\/13"}],"replies":[{"embeddable":true,"href":"https:\/\/www.caltagmedsystems.co.uk\/information\/wp-json\/wp\/v2\/comments?post=2250"}],"version-history":[{"count":7,"href":"https:\/\/www.caltagmedsystems.co.uk\/information\/wp-json\/wp\/v2\/posts\/2250\/revisions"}],"predecessor-version":[{"id":2268,"href":"https:\/\/www.caltagmedsystems.co.uk\/information\/wp-json\/wp\/v2\/posts\/2250\/revisions\/2268"}],"wp:attachment":[{"href":"https:\/\/www.caltagmedsystems.co.uk\/information\/wp-json\/wp\/v2\/media?parent=2250"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.caltagmedsystems.co.uk\/information\/wp-json\/wp\/v2\/categories?post=2250"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.caltagmedsystems.co.uk\/information\/wp-json\/wp\/v2\/tags?post=2250"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}